125 related articles for article (PubMed ID: 8788438)
21. Evidence for specific interactions between 5-HT1A and dopamine D2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat.
Wadenberg ML; Cortizo L; Ahlenius S
Pharmacol Biochem Behav; 1994 Mar; 47(3):509-13. PubMed ID: 8208768
[TBL] [Abstract][Full Text] [Related]
22. Microcatalepsy and disruption of forelimb usage during operant behavior: differences between dopamine D1 (SCH-23390) and D2 (raclopride) antagonists.
Fowler SC; Liou JR
Psychopharmacology (Berl); 1994 Jun; 115(1-2):24-30. PubMed ID: 7862901
[TBL] [Abstract][Full Text] [Related]
23. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
Wadenberg MG; Browning JL; Young KA; Hicks PB
Pharmacol Biochem Behav; 2001 Mar; 68(3):363-70. PubMed ID: 11325387
[TBL] [Abstract][Full Text] [Related]
24. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
Protais P; Lesourd M; Comoy E
Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
[TBL] [Abstract][Full Text] [Related]
25. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
Wardas J; Pietraszek M; Ossowska K; Wolfarth S
Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
[TBL] [Abstract][Full Text] [Related]
26. Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats.
Bishop C; Walker PD
Neuroscience; 2003; 121(3):649-57. PubMed ID: 14568025
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys.
Winsauer PJ; Moerschbaecher JM
Behav Pharmacol; 2000 Nov; 11(7-8):535-53. PubMed ID: 11198126
[TBL] [Abstract][Full Text] [Related]
28. Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors.
Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Hill JL; Murphy DL
Psychopharmacology (Berl); 1995 Jan; 117(2):193-9. PubMed ID: 7753967
[TBL] [Abstract][Full Text] [Related]
29. Supraspinal mediation of dopamine-serotonin interactions in extrapyramidal motor functions in the rat.
Wadenberg ML; Hillegaart V; Berge OG
Neuroreport; 1993 Jan; 4(1):59-61. PubMed ID: 8384019
[TBL] [Abstract][Full Text] [Related]
30. Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT(2A) receptor antagonism on the firing activity of norepinephrine neurons.
Szabo ST; Blier P
J Pharmacol Exp Ther; 2002 Sep; 302(3):983-91. PubMed ID: 12183655
[TBL] [Abstract][Full Text] [Related]
31. Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats.
Hauber W; Neuscheler P; Nagel J; Müller CE
Eur J Neurosci; 2001 Oct; 14(8):1287-93. PubMed ID: 11703457
[TBL] [Abstract][Full Text] [Related]
32. Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
Done CJ; Sharp T
Br J Pharmacol; 1992 Sep; 107(1):240-5. PubMed ID: 1422575
[TBL] [Abstract][Full Text] [Related]
33. Effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on plasma glucose and glucagon levels of rats.
Sugimoto Y; Yamada J
Biol Pharm Bull; 2000 Dec; 23(12):1521-3. PubMed ID: 11145190
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
35. Evidence for specific involvement of dopamine D1 and D2 receptors in the regulation of body temperature in the rat.
Salmi P; Jimenez P; Ahlenius S
Eur J Pharmacol; 1993 Jun; 236(3):395-400. PubMed ID: 8102971
[TBL] [Abstract][Full Text] [Related]
36. Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.
Lublin H; Gerlach J; Peacock L
Psychopharmacology (Berl); 1993; 112(2-3):389-97. PubMed ID: 7871047
[TBL] [Abstract][Full Text] [Related]
37. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
[TBL] [Abstract][Full Text] [Related]
38. Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat.
Silvestre JS; O'Neill MF; Fernandez AG; Palacios JM
Eur J Pharmacol; 1996 Dec; 318(2-3):257-65. PubMed ID: 9016913
[TBL] [Abstract][Full Text] [Related]
39. The serotonin (5-HT)1A agonist, LY 165,163, induces contralateral rotation in unilateral substantia nigra-lesioned rats via dopamine receptors.
Millan MJ; Bervoets K; Mavridis M
Neurosci Lett; 1991 Sep; 130(2):173-6. PubMed ID: 1795876
[TBL] [Abstract][Full Text] [Related]
40. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
Mechan AO; Esteban B; O'Shea E; Elliott JM; Colado MI; Green AR
Br J Pharmacol; 2002 Jan; 135(1):170-80. PubMed ID: 11786492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
